Drugmakers Realign To Reduce Costs

Meanwhile, their trade group warns that the patient cost-sharing requirements in some health law plans could restrict prescription drug access.

NPR: Drug Industry Moves To Cut Costs, Banks On Future Big Sellers
Bayer has announced it is buying Merck's consumer drugs business, and Pfizer is trying to take over AstraZeneca. Why is this reorganization happening now, and what does it mean for drug development? (Hensley, 5/8).

Kaiser Health News: Capsules: Castellani: Health Law’s Cost-Sharing Could Limit Patient Access To Prescription Drugs
Enrollees in some of the health law’s most popular plans will face high cost-sharing requirements that the pharmaceutical industry says could keep patients from getting the drugs they need (Carey, 5/7). 

This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from major news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.